Tiova Rotacap (Tiotropium Bromide)

Tiova Rotacap (Tiotropium Bromide): Patient-Friendly Medicine Information for Australia

1. Basic Product Information

2. Mechanism of Action

For Patients: Tiova Rotacap contains tiotropium bromide, a long-acting medicine that helps open your airways. It relaxes the muscles around your airways, making it easier for you to breathe. Tiotropium is often called a “bronchodilator” and is commonly used in conditions where breathing feels tight, such as chronic obstructive pulmonary disease (COPD) and long-standing asthma.

For Healthcare Professionals: Tiotropium bromide is a long-acting, muscarinic receptor antagonist (LAMA). Its primary action is competitive inhibition at M3-muscarinic receptors on airway smooth muscles, which leads to sustained bronchodilation for at least 24 hours after inhalation.

3. Pharmacokinetics

• Absorption: Approximately 19% of inhaled dose reaches the lungs. Peak plasma concentrations occur within 5–7 minutes post-inhalation.
• Metabolism: Undergoes limited hepatic metabolism via CYP2D6 and CYP3A4; most is excreted unchanged.
• Elimination: Major excretion via urine (approximately 74%), minor via faeces.
• Duration of Action: 24 hours, supporting once-daily dosing.

4. Use in Everyday Life and Best Practices

Tiova Rotacap is typically prescribed to be used once per day. Each Rotacap contains a measured dose (18 micrograms) of tiotropium and is intended to be inhaled using a Rotahaler device (sold separately from the capsules).

1. Wash your hands and ensure the inhalation device is clean and dry.
2. Separate a capsule (Rotacap) from the strip and insert it into the inhaler device.
3. Follow the device instructions—usually, you pierce the capsule and inhale the powder deeply.
4. Do not swallow the capsules—they are for inhalation only.
5. Discard the used capsule and clean the inhaler regularly.
6. Try to take your dose at the same time each day for best results.

Store capsules in the original packaging at room temperature, away from moisture. Do not refrigerate or freeze.

Tiova Rotacap is commonly used for chronic airway conditions—regular use maximises benefit. If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose. Never double your dose.

5. Dosing: Morning vs Evening

Morning dosing: Most patients in Australia are advised to take Tiova in the morning. This fits with typical routines and helps maximise protection during daily activity, when symptoms are often worse.

Evening dosing: If symptoms are more troublesome at night or on waking, your doctor might recommend evening administration.

General Advice: Consistency is key—take this medicine at the same time each day. Choose a time that best suits your schedule and stick with it.

6. Taking With Food or on an Empty Stomach

Meals do not affect the action of Tiova Rotacap, as it is inhaled and not absorbed via the stomach. You can use your inhaler before or after food. There are no special dietary precautions for Australian patients. However, a healthy, varied diet is beneficial for lung health.

7. Interaction Warnings

8. Indications

9. Dosing According to Clinical Indications

*Tiotropium is not commonly prescribed to children in Australia, except under specialist supervision.

10. Safety Profile and Side Effects

• Do not allow powder to enter your eyes: may cause blurred vision or eye pain.
• If swallowing, difficulty passing urine, or severe constipation occurs, inform your doctor.
• If breathing becomes suddenly worse, seek immediate medical help.

11. Guidelines for Proper Use

• Do not swallow Rotacaps—use only with an appropriate inhaler device.
• Ensure device is kept clean, dry, and used correctly. Seek pharmacist demonstration on first use.
• Do not exceed the recommended dose; more is not better for symptom relief.
• If you use other inhaled medications, use them as directed, and always rinse your mouth after steroid inhalers (not required after tiotropium alone).
• If hospitalised or starting new medicines, always inform your care team that you use tiotropium.
• In Australia's climate, store Rotacaps away from excess heat and humidity.
• Dispose of expired or unused capsules via a pharmacy medicine return scheme.

12. Alternative Treatment Options

• LAMAs (other than tiotropium): Aclidinium (Brette), Glycopyrronium (Seebri), Umeclidinium (Incruse)—similar action, different devices.
• LABAs (long-acting beta agonists): Salmeterol, Formoterol—often used in combination inhalers.
• Combination inhalers: LAMA/LABA (e.g., Spiolto, Anoro); LAMA/LABA/ICS (e.g., Trelegy Ellipta)—once daily, triple therapy for advanced disease.
• Inhaled corticosteroids (ICS): Fluticasone, Budesonide—mainly for asthma or frequent COPD exacerbations.

13. Legal, Registration, and Reimbursement Status in Australia

• Registered with the Therapeutic Goods Administration (TGA)
• Listed on the Pharmaceutical Benefits Scheme (PBS) for COPD and as add-on therapy for asthma
• Prescription only (Schedule 4 – S4) – must be prescribed by a registered medical practitioner
• Subsidised for eligible patients via Medicare/PBS; dispense through community pharmacy
• Monthly repeat prescriptions are typical; stricter controls for bulk or private supply

14. Latest Research and Clinical Guidance (2022–2025)

• 2024 GOLD guidelines support tiotropium as a principal inhaled bronchodilator for moderate to severe COPD, alone or in combination with LABAs/ICS.
• Recent Australian studies confirm tiotropium’s role in reducing COPD exacerbations and hospital admissions (Source: Med J Aust. 2023; Lancet Respir Med. 2024).
• Tiotropium well-tolerated in elderly, but caution with kidney impairment and glaucoma (Eur Respir J. 2022).
• Asthma guidelines (Australian Asthma Handbook, v2.2, 2023) recommend tiotropium as an add-on step for adults and adolescents if symptoms remain uncontrolled with ICS/LABA.
• Combination inhalers may be preferred in advanced disease for simplicity and adherence.

15. Availability and Delivery

*Prices as per 2024-2025 PBS schedule. Actual patient co-pay may vary by eligibility and pharmacy.

16. Frequently Asked Questions (FAQs)

1. Can I use Tiova Rotacap during pregnancy or breastfeeding?
   Tiova Rotacap is not generally recommended during pregnancy or breastfeeding unless clearly indicated. Consult your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
2. Can I take Tiova with my other asthma or COPD inhalers?
   Yes, Tiova can usually be combined safely with other inhaled medicines, such as corticosteroids or long-acting beta agonists. Always follow your asthma/COPD management plan and inform your doctor of all medications you use.
3. Is it safe to use Tiova long-term?
   Yes. Tiova Rotacap is designed for long-term maintenance therapy and has a well-established safety record. Your doctor will regularly review your ongoing need.
4. I’ve swallowed the capsule by mistake. What should I do?
   The capsule is unlikely to cause harm if swallowed, but will not work for your lungs. Simply skip the missed inhaled dose and continue as normal the next day. If you feel unwell, contact your doctor.
5. What should I do if my symptoms get worse despite using Tiova?
   If you are experiencing worsening breathlessness, wheezing, or increased use of reliever (blue puffer) inhalers, seek urgent medical attention. Do not increase the dose of Tiova without guidance.

Speak to your doctor or pharmacist for personalised advice, training on inhaler technique, or if you have any concerns regarding your medicine.